BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19265691)

  • 21. Thymidine kinase 2 deficiency-induced mtDNA depletion in mouse liver leads to defect β-oxidation.
    Zhou X; Kannisto K; Curbo S; von Döbeln U; Hultenby K; Isetun S; Gåfvels M; Karlsson A
    PLoS One; 2013; 8(3):e58843. PubMed ID: 23505564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion.
    Mousson de Camaret B; Taanman JW; Padet S; Chassagne M; Mayençon M; Clerc-Renaud P; Mandon G; Zabot MT; Lachaux A; Bozon D
    Biochem J; 2007 Mar; 402(2):377-85. PubMed ID: 17073823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term expression of Drosophila melanogaster nucleoside kinase in thymidine kinase 2-deficient mice with no lethal effects caused by nucleotide pool imbalances.
    Krishnan S; Paredes JA; Zhou X; Kuiper RV; Hultenby K; Curbo S; Karlsson A
    J Biol Chem; 2014 Nov; 289(47):32835-44. PubMed ID: 25296759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion.
    Zhang S; Li FY; Bass HN; Pursley A; Schmitt ES; Brown BL; Brundage EK; Mardach R; Wong LJ
    Mol Genet Metab; 2010 Jan; 99(1):53-7. PubMed ID: 19815440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic biochemical characterization of cytosolic enzymes in thymidine nucleotide synthesis in adult rat tissues: implications for tissue specific mitochondrial DNA depletion and deoxynucleoside-based therapy for TK2-deficiency.
    Wang L; Sun R; Eriksson S
    BMC Mol Cell Biol; 2020 Apr; 21(1):33. PubMed ID: 32345222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA.
    Curbo S; Johansson M; Balzarini J; Lewis LD; Karlsson A
    Exp Cell Res; 2009 Sep; 315(15):2539-43. PubMed ID: 19481540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A defect in the thymidine kinase 2 gene causing isolated mitochondrial myopathy without mtDNA depletion.
    Leshinsky-Silver E; Michelson M; Cohen S; Ginsberg M; Sadeh M; Barash V; Lerman-Sagie T; Lev D
    Eur J Paediatr Neurol; 2008 Jul; 12(4):309-13. PubMed ID: 17951082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disorders of nuclear-mitochondrial intergenomic signaling.
    Spinazzola A; Zeviani M
    Gene; 2005 Jul; 354():162-8. PubMed ID: 15921863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The first founder DGUOK mutation associated with hepatocerebral mitochondrial DNA depletion syndrome.
    Brahimi N; Jambou M; Sarzi E; Serre V; Boddaert N; Romano S; de Lonlay P; Slama A; Munnich A; Rötig A; Bonnefont JP; Lebre AS
    Mol Genet Metab; 2009 Jul; 97(3):221-6. PubMed ID: 19394258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
    Lopez-Gomez C; Hewan H; Sierra C; Akman HO; Sanchez-Quintero MJ; Juanola-Falgarona M; Tadesse S; Tanji K; Konofagou EE; Hirano M
    EBioMedicine; 2019 Aug; 46():356-367. PubMed ID: 31383553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial thymidine kinase 2 but not deoxyguanosine kinase is up-regulated during the stationary growth phase of cultured cells.
    Sun R; Eriksson S; Wang L
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):282-6. PubMed ID: 24940680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retained sensitivity to cytotoxic pyrimidine nucleoside analogs in thymidine kinase 2 deficient human fibroblasts.
    Bjerke M; Solaroli N; Lesko N; Balzarini J; Johansson M; Karlsson A
    Nucleosides Nucleotides Nucleic Acids; 2010 Jan; 29(1):1-13. PubMed ID: 20391188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance.
    Akman HO; Dorado B; López LC; García-Cazorla A; Vilà MR; Tanabe LM; Dauer WT; Bonilla E; Tanji K; Hirano M
    Hum Mol Genet; 2008 Aug; 17(16):2433-40. PubMed ID: 18467430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum.
    Béhin A; Jardel C; Claeys KG; Fagart J; Louha M; Romero NB; Laforêt P; Eymard B; Lombès A
    Neurology; 2012 Feb; 78(9):644-8. PubMed ID: 22345218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted transgenic overexpression of mitochondrial thymidine kinase (TK2) alters mitochondrial DNA (mtDNA) and mitochondrial polypeptide abundance: transgenic TK2, mtDNA, and antiretrovirals.
    Hosseini SH; Kohler JJ; Haase CP; Tioleco N; Stuart T; Keebaugh E; Ludaway T; Russ R; Green E; Long R; Wang L; Eriksson S; Lewis W
    Am J Pathol; 2007 Mar; 170(3):865-74. PubMed ID: 17322372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of thymidine kinase 2 alters neuronal bioenergetics and leads to neurodegeneration.
    Bartesaghi S; Betts-Henderson J; Cain K; Dinsdale D; Zhou X; Karlsson A; Salomoni P; Nicotera P
    Hum Mol Genet; 2010 May; 19(9):1669-77. PubMed ID: 20123860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myopathic mtDNA Depletion Syndrome Due to Mutation in TK2 Gene.
    Martín-Hernández E; García-Silva MT; Quijada-Fraile P; Rodríguez-García ME; Rivera H; Hernández-Laín A; Coca-Robinot D; Fernández-Toral J; Arenas J; Martín MA; Martínez-Azorín F
    Pediatr Dev Pathol; 2017; 20(5):416-420. PubMed ID: 28812460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations.
    Freisinger P; Fütterer N; Lankes E; Gempel K; Berger TM; Spalinger J; Hoerbe A; Schwantes C; Lindner M; Santer R; Burdelski M; Schaefer H; Setzer B; Walker UA; Horváth R
    Arch Neurol; 2006 Aug; 63(8):1129-34. PubMed ID: 16908739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications.
    Priego EM; Karlsson A; Gago F; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
    Curr Pharm Des; 2012; 18(20):2981-94. PubMed ID: 22571666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.
    El-Hattab AW; Scaglia F
    Neurotherapeutics; 2013 Apr; 10(2):186-98. PubMed ID: 23385875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.